Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.33 |
| ▸ | PLK1 | P53350 | 1/20 | 0.33 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.33 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.32 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
| ▸ | BUB1 | O43683 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6165167 | 0.81 | HTT (1.00) | HTTCSNK2A1PLK1PLK3BUB1 | |
| SCHEMBL6166704 | 0.81 | HTT (0.64) | HTTCSNK2A1PLK1PLK3CSNK2B | |
| SCHEMBL6166619 | 0.79 | HTT (0.42) | HTTCSNK2A1PLK1PLK3CSNK2B | |
| SCHEMBL6164263 | 0.78 | HTT (0.41) | HTTCSNK2A1CSNK2BCSNK2A2ABCG2 | |
| SCHEMBL6164718 | 0.78 | HTT (0.41) | HTTBUB1OPRM1 | |
| SCHEMBL6165245 | 0.77 | HTT (0.68) | HTTCSNK2A1PLK1PLK3BUB1 | |
| SCHEMBL6163627 | 0.77 | HTT (0.40) | HTT | |
| SCHEMBL6164099 | 0.76 | HTT (0.66) | HTTCSNK2A1PLK1PLK3BUB1 | |
| SCHEMBL6168258 | 0.75 | HTT (0.65) | HTTCSNK2A1PLK1PLK3BUB1 | |
| SCHEMBL6167101 | 0.75 | HTT (0.56) | HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1177185-B1 | 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS | PHARMACIA ITALIA SPA (IT) | 2005-04-20 | — | — | EP | disclosed |
| US-6716856-B1 | CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY | PHARMACIA & TUBJOHN SPA (IT) | 2004-04-06 | — | — | US | disclosed |